Detailed information for compound 345314

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 244.719 | Formula: C14H13ClN2
  • H donors: 1 H acceptors: 1 LogP: 2.73 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc2c(n1)cc1c(c2)C2CC1CNC2
  • InChi: 1S/C14H13ClN2/c15-14-2-1-8-4-11-9-3-10(7-16-6-9)12(11)5-13(8)17-14/h1-2,4-5,9-10,16H,3,6-7H2
  • InChiKey: SRJJMFYWQLESEK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Neuronal acetylcholine receptor; alpha4/beta2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.2877 0.1395 0.1537
Onchocerca volvulus Matrix metalloproteinase homolog 0.5239 0.4954 1
Wolbachia endosymbiont of Brugia malayi extracellular metallopeptidase 0.6225 0.6439 0.5
Schistosoma mansoni matrix metallopeptidase-7 (M10 family) 0.2362 0.0619 0.294
Loa Loa (eye worm) matrixin family protein 0.5239 0.4954 0.859
Mycobacterium tuberculosis Probable peptidoglycan hydrolase 0.2877 0.1395 0.5
Loa Loa (eye worm) matrixin family protein 0.5712 0.5665 1
Echinococcus multilocularis matrix metallopeptidase 7 (M10 family) 0.8589 1 0.5
Brugia malayi Hemopexin family protein 0.335 0.2107 0.2947
Mycobacterium ulcerans hydrolase 0.2877 0.1395 0.5
Schistosoma mansoni hypothetical protein 0.335 0.2107 1
Mycobacterium leprae PROBABLE HYDROLASE 0.2877 0.1395 0.5
Brugia malayi Matrix metalloprotease, N-terminal domain containing protein 0.2877 0.1395 0.1537
Brugia malayi Matrixin family protein 0.5712 0.5665 1
Onchocerca volvulus 0.335 0.2107 0.3431
Onchocerca volvulus Matrilysin homolog 0.5239 0.4954 1

Activities

Activity type Activity value Assay description Source Reference
Efficacy (functional) = 300 % Efficacy against human Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes at 10 uM relative to 10 uM nicotine ChEMBL. 16171993
Efficacy (functional) = 300 % Efficacy against human Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes at 10 uM relative to 10 uM nicotine ChEMBL. 16171993
Inhibition (functional) = 250 % Percent inhibition against 10 uM nicotine binding to human Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes at 10 uM ChEMBL. 16171993
Inhibition (functional) = 250 % Percent inhibition against 10 uM nicotine binding to human Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes at 10 uM ChEMBL. 16171993
Ki (binding) = 0.27 nM Binding affinity to rat cortex Nicotinic acetylcholine receptor alpha4-beta2 using [3H]-nicotine ChEMBL. 16171993
Ki (binding) = 0.27 nM Binding affinity to rat cortex Nicotinic acetylcholine receptor alpha4-beta2 using [3H]-nicotine ChEMBL. 16171993

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.